LumiraDx (LMDX) Cash on Hand

Price: $0.016
Market Cap: $5.10M
Avg Volume: 120.55M
Country: GB
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Beta: 1.713
52W Range: $0.0151-0.0282
Website: LumiraDx
How much cash does LumiraDx have?

According to LumiraDx's latest annual financial reports, the company has a total of $100.01M in cash and cash equivalents. This amount includes all liquid assets that can be readily converted into cash.

Additionally, LumiraDx holds $- in short-term investments, which are highly liquid assets that can be easily converted into cash within a short period.

In total, the company has $100.01M when combining cash and cash equivalents with short-term investments.

On a per-share basis, LumiraDx has $0.35 in cash. This metric helps investors understand how much cash the company holds per outstanding share.

The company's free cash flow, which is the cash generated from operations after deducting capital expenditures, stands at $-187.09M. This is an important indicator of financial health, showing the cash available for distribution to shareholders or reinvestment into the company.

Lastly, the company's cash position has experienced a growth rate of -24.32%, reflecting the increase in cash and cash equivalents over the specified period.

Cash & Cash Equivalents

$100.01M

Short-Term Investments

$-

Cash & Short-Term Investments

$100.01M

Cash Per Share

$0.35

Free Cash Flow

$-187.09M

Cash Growth

-24.32%

LumiraDx Historical Cash on Hand
$180.00M$180.00M$160.00M$160.00M$140.00M$140.00M$120.00M$120.00M$100.00M$100.00M$80.00M$80.00MCash on Hand20202020Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '22
Cash on Hand History

The table below shows the amount of cash on hand for each year, with the latest data available for the last fiscal year 2022.

Year Cash on Hand Change
2022 $100.01M -24.32%
2021 $132.15M -16.74%
2020 $158.72M 13.87%
2019 $139.39M N/A

Related Metrics

Explore detailed financial metrics and analysis for LMDX.